Skip to main content

Table 3 Escherichia coli non-susceptibility rates a for cases with available clinical data

From: Cefditoren: Comparative efficacy with other antimicrobials and risk factors for resistance in clinical isolates causing UTIs in outpatients

Antimicrobial agent AUC (n = 119) TotalE. coli cases with available clinical info (n = 214)
Amoxicillin 26.1 27.6
Amoxicillin/clavulanic acid 5.0 4.7
Cefalothin 6.7 7.9
Cefuroxime sodiumb 0.8 1.4
Cefuroxime axetilc 2.5 3.3
Co-trimoxazole 18.5 18.7
Nalidixic acid 5.0 7.9
Ciprofloxacin 1.7 4.2
Mecillinam 2.5 2.8
Nitrofurantoin 7.6 7.0
Fosfomycin d 0 0.5
Cefotaxime 0.8 2.3
Ceftazidime 0 0
Gentamicin 0 1.4
Netilimicin 0 0.5
Amikacin 0 0
Piperacillin-tazobactam 0 0
Ticarcillin-clavulanate 0.8 0.9
Imipenem 0 0
Cefditoren 1.7 1.9
  1. AUC. acute uncomplicated cystitis; a CLSI 2011 breakpoints of susceptibility were applied; bResults reported according to the breakpoint of parenteral cefuroxime; c Results reported according to the breakpoint of oral cefuroxime; d Fosfomycin trometamol is no long marketed in Greece.